HubXchange San Francisco 2022 – March 31

Roundtable Discussion

Dan Norton

Dan Norton
Personalis, Inc.

Thursday, March 31 

Beyond MRD: Developing Patient-Centered Diagnostics through Tumor-Informed Comprehensive Insights

  • Earlier detection of disease recurrence
  • Utility in more disease indications, and at earlier stages of disease
  • Clinical trial needs for patient enrichment
  • Screening/enrollment
  • Surrogate endpoint analysis
  • Necessity for additional biomarker readouts

HubXchange San Francisco, March 31, 2022